RIGONTEC (U.S. Trademark Serial Number 79189452) is a United States trademark of Rigontec GmbH. The goods and services include: Pharmaceutical preparations for the treatment of cancer, infectious diseases, inflammatory diseases or other diseases with an underlying aberration of the immune system Chemical preparations for scientific purposes Scientific and industrial research in the field of immunotherapeutics. The correspondent is DR. STEFAN SCHUPPER; HOGAN LOVELLS INTER of ALSTERTOR 21.

This trademark was filed on May 03, 2016 as United States Trademark Application Serial Number 79189452. The trademark application was registered on July 04, 2017 as U.S. Trademark Registration 5234342.

Trademark PTO Status History

July 04, 2022 – COURTESY REMINDER – SEC. 71 (6-YR) E-MAILED

October 28, 2017 – FINAL DECISION TRANSACTION PROCESSED BY IB

October 06, 2017 – FINAL DISPOSITION NOTICE SENT TO IB

October 06, 2017 – FINAL DISPOSITION PROCESSED

October 04, 2017 – FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

July 04, 2017 – REGISTERED-PRINCIPAL REGISTER

April 18, 2017 – OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

April 18, 2017 – PUBLISHED FOR OPPOSITION

View full trademark status information at USPTO

Ownership History

Rigontec GmbH

Rigontec GmbH

Rigontec GmbH

View documents on file at USPTO

File a Trademark or Get Help With Trademark Law

Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.